Kiniksa Pharma Reports Q4 ARCALYST Revenue Of $121.9M, Cash Balance Of $243.6M

Benzinga20:40

Express News | Kiniksa Pharmaceuticals International PLC - Arcalyst 2024 Net Product Rev $416.4 Million, 79% YoY Growth

Breakings20:31

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Climbs 3.6% This Week, Taking Three-year Gains to 83%

Simply Wall StJan 6 18:19

Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Kiniksa PharmaceuticalsJan 6 13:00

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference

Kiniksa PharmaceuticalsNov 26, 2024 13:00

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $357,680, According to a Recent SEC Filing

MT NewswiresNov 21, 2024 05:43